Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia.
Hauswirth
Alexander W
AW
Jäger
Ulrich
U
D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D018899:CpG Islands; D020732:Cytogenetic Analysis; D018572:Disease-Free Survival; D020022:Genetic Predisposition to Disease; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy*; D008495:Medical Oncology / Q000379:methods*; D008957:Models, Genetic; D010597:Pharmacogenetics; D011379:Prognosis; D016896:Treatment Outcome
D014408:Biomarkers, Tumor